Piramal Turbhe Warning: Shocking cGMP Violations Exposed
The Piramal Turbhe warning has sent shockwaves through the pharmaceutical industry, revealing shocking cGMP violations that put product quality and patient safety at risk. As regulatory bodies and industry stakeholders scramble to address these grave concerns, this article dives into the details of the infractions and their far-reaching implications.








